ClinicalTrials.govpublic full text
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
breast cancer, triple negative breast cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995141
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.